Novavax
NVAX
#5460
Rank
S$1.75 B
Marketcap
S$10.79
Share price
-0.70%
Change (1 day)
20.33%
Change (1 year)

Novavax (NVAX) - P/B ratio

P/B ratio as of April 2026 : -10.9

According to Novavax's latest financial reports the company has a price-to-book ratio of 1.35842.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Novavax - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31-7.40247.83%
2024-12-31-2.13167.32%
2023-12-31-0.7953-42.29%
2022-12-31-1.38-95.52%
2021-12-31-30.8-371.78%
2020-12-3111.3-1735.05%
2019-12-31-0.6922-83.57%
2018-12-31-4.21-7.94%
2017-12-31-4.58-92.57%
2016-12-31-61.6-896.25%
2015-12-317.7425.48%
2014-12-316.1717.34%
2013-12-315.2650.85%
2012-12-313.4829.53%
2011-12-312.69-41.12%
2010-12-314.5719.85%
2009-12-313.8132.66%
2008-12-312.87-12.14%
2007-12-313.2721.37%
2006-12-312.70-36.5%
2005-12-314.249.54%
2004-12-313.87-33.15%
2003-12-315.80-27.94%
2002-12-318.04

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Novartis
NVS
6.43-159.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.78-116.38%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
6.52-159.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
5.43-149.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
2.05-118.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
5.00-145.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-0.6084-94.41%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
3.19-129.29%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-20.8 91.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
0.7510-106.90%๐Ÿ‡บ๐Ÿ‡ธ USA